Tuesday, 2 February 2016

10

9

8

7

6

5 Timeline

  1. Spoke to Terry; feb 3rd; Prof has aptients with Card am. invlloved ,steady.

4

3

2 Hypothesis

  1. Feb 4th, 2016 They propose that normal tissue becomes primed for cancer when oncogenes are activated and tumor suppressor genes are silenced or lost, but that cancer develops only when a cell in the tissue reverts to a more primitive, embryonic state and starts dividing. (Science Today)
  2. Restated Boston Children's Hospital. "We found that the beginning of cancer occurs after activation of an oncogene or loss of a tumor suppressor, and involves a change that takes a single cell back to a stem cell state."
  3. Amyloidosis- mono or polyclonal?
  4. The key paper is Pepys Lab 2015 that we interpret as follows " you can stick whatever you like on the amyloid but until igG1 ( 66% of human antibodies -wiki) is there in sufficient levels to trigger FBGC or MGC formation to engulf the amyloid fibrils, you can whistle Dixie. Evidence in favour of this proposition is Pepys amyloid phase 2 was slow until threshold of fully humanised monoclonal IgG1 SAP was introduced and then clearance happened in 14 days. 
  5. Golombick et al curcumin retards paraprotein level but clearance is slow in agreement with 4 above assertion.
  6. so we have 2 paths, 
    1. deal with GlaxoSmith Kline or find an alternative supplier and write a patent
    2. ld IgG1 levels internally and talk to JL nephew as to whether endogenous is good enough or an exogeneous material must be conditioned to SAP before introducing. 
    3. internal may be possible via GH stimulation or other eg (1), (2), (3), (4), (5), (6), (7)
  7. we go with X

Feb 2016 Protocol

  1.  Re-hydrate for cell volume (Altland)
  2. Neutral pH of saliva and urine ( Altland)
  3. diet-
  4. bibs and bobs foods  for heart etc, defib training
  5. Assume Metabolic  trigger- 
  6. Preferably stress with KD, and or eK
  7. attack of poly-clonal family down to resistant monoclone hypothesis
  8. fast- DCA, chemo CyBorD
  9. slow curcumin, green tea
  10. add nitro for angina due to precipitate in porosity and attachment of chlomcron fats reducing flow
  11. Hi P Oxygen therapy
  12. Endogenous or exogenous conditioned IgG1 
  13. measure routinely ( monthly)


1 Literature 2016 Search

Amyloid Destruction

Mark Pepys MGC Nov 2015
dietry PUFA Macrophage Autophagy
 autophagy in diabetic heart
Peter anti PUFA
Pepys NEJM 2015
pepys Clinical trial Gov registration
Pepys ppt 2011 amyloid redcution ideas 
Amyloid Autopsy 1949
macrophage and thyroid
Endocrine Review GH Lymphocytes


Cell Chemo

 merlini 2013
Miles Prince


 Curcumin et al

Laryngeal Amyloidosis long term curcumin
Palladini 2015
Meriva SR curcumin subset

DCA

ABC Canberra Hospital
DCA Canberra Trial
Thiamine
Thiamine detailed
Mito DCA Synthesis
DCA Case study
rechecked DCA Canberra trial

General

Simon Gibbs Patient
Snoring device Hypoxia night
Snoring Dentist

Dom et al

Dom facebook
Dom Deuterium
Dom Tim Ferriss transribed somewhat
Dom with Tim Ferriss
Dom video 2014
Powdered MCT australia
Powdered MCT UK
Dom Greenfield ketosis practical
 Cancer as a metabolic disease Seyfield
Dom ketosis 1 hour podcast
Dom contact details
Dom Poff Rats and exogeneous ketones , cancer
Dom website for ketones
Hyperbaric oxygen

Metformin 


Metformin Inflam
XXX 2015 Metformin decreases pro-form of inflammatory cytokine IL-1β in response to LPS in macrophages.specifically inhibited pro-IL-1β production, having no effect on TNF-α. Furthermore, metformin boosted induction of the anti-inflammatory cytokine IL-10
metformin Bone Marrow
LPS Immunity after chemo - rats

 Oddities

evernotes paperless technique
japanese Kondo Tidying up book
Pet owners worry about animals while away
Mindahome couple at auburn road jr with weekly fluid iv
Bra changes blog
Linda Bra in Qld
She Science sports bra Kew
Better Vit D lotion
FIJI Boys 8 biases
BBC brain conditioning
grow your own moss
artificial rocks
jap garden in french calming


Allergy and Inflammation Quenching

Coca Pulse test 
 Green Tea remodels seminal amyloid